Efficacy of a third BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL who failed standard 2-dose vaccination

Autor: Herishanu, Yair *, Rahav, Galia, Levi, Shai, Braester, Andrei, Itchaki, Gilad, Bairey, Osnat, Dally, Najib, Shvidel, Lev, Ziv-Baran, Tomer, Polliack, Aaron, Tadmor, Tamar *, Benjamini, Ohad *
Zdroj: In Blood 3 February 2022 139(5):678-685
Databáze: ScienceDirect